Palantir Technologies Inc. and Gemelli Generator Real World Data (RWD), a research center at Fondazione Policlinico Universitario A. Gemelli IRCCS, announced a partnership to implement digital medicine research solutions that leverage artificial intelligence to improve patient care and health outcomes.
The digital research center of the Gemelli Polyclinic, Generator RWD, will use Palantir Foundry as one of the main enabling platforms to manage the volume and complexity of healthcare data. Foundry’s AI capabilities will be used to generate Real World Evidence to support clinical and translational research aimed at drug and indication discovery, improving patient care and developing digital medicine solutions for healthcare research in Italy and as part of their global partnerships.
Palantir software will enhance the capabilities of Generator RWD and its partner network as they continue their quest to more efficiently use data to gain valuable new insights across numerous healthcare research domains.
“Healthcare is transforming thanks to the power of data and artificial intelligence, and this trend will only accelerate. A growing number of companies are using this power to discover innovative therapies, improve patient care techniques and increase the efficiency and effectiveness of treatments,” explains Andrea Galvagni, Director for Italy at Palantir. “At Palantir, we are proud to support world-leading institutions like Policlinico Gemelli by providing the technology they need to achieve their most mission-critical missions.”
“Real World Evidence becomes increasingly important in supporting healthcare research. By integrating Foundry into the framework developed at Generator RWE, we aim to accelerate the cycles of our research pipeline to achieve faster and better results,” said Vincenzo Valentini, Scientific Director of Gemelli Generator Research Facility.
“The added value of Palantir software and their great capabilities in data-driven innovation will enrich the suite of products and services that we are providing as part of co-creation projects together with our industrial partners,” concludes Alfredo Cesario, CEO Gemelli Digital Medicine & Health.
SOURCE: BusinessWire
